Search

everythinglearnresearchcommunity

for

Search:↓

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

New understanding and treatments for hair loss are improving, but more research is needed.

Use antiandrogens and other treatments for hair loss.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Finasteride doesn't affect oral testosterone undecanoate, and high DHT levels may cause acne, prostate issues, and hair loss.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

The Shen Bai Hair Growing Decoction may help treat hair loss by promoting hair growth and reducing inflammation.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Common skin conditions can greatly affect a person's mental health and social life.

Men and women react differently to opioids, with hormones potentially influencing these differences.

New treatments targeting insulin, blood flow, and inflammation could improve hormone-related hair conditions with fewer side effects.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

Antibody treatments show promise for hair loss but need more research.